CAT

910.83

+1.65%↑

335.2

+0.88%↑

GEV.US

939.9

+3.99%↑

RTX

183.52

-0.15%↓

219.17

-0.89%↓

CAT

910.83

+1.65%↑

335.2

+0.88%↑

GEV.US

939.9

+3.99%↑

RTX

183.52

-0.15%↓

219.17

-0.89%↓

CAT

910.83

+1.65%↑

335.2

+0.88%↑

GEV.US

939.9

+3.99%↑

RTX

183.52

-0.15%↓

219.17

-0.89%↓

CAT

910.83

+1.65%↑

335.2

+0.88%↑

GEV.US

939.9

+3.99%↑

RTX

183.52

-0.15%↓

219.17

-0.89%↓

CAT

910.83

+1.65%↑

335.2

+0.88%↑

GEV.US

939.9

+3.99%↑

RTX

183.52

-0.15%↓

219.17

-0.89%↓

Начало・Списък с акции・Ocugen Inc

Ocugen Inc

Затворен

1.21 -1.63

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.2

Максимум

1.24

Ключови измерители
By Trading Economics
Приходи	-1.5M -19M
Продажби	1.7M 1.5M
EPS	-0.06
Марж на печалбата	-1,250.946
Служители	116
EBITDA	-987K -17M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+692.62% upside

Дивиденти
By Acuity
Следващи печалби	31.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-193M 433M
Предишно отваряне	2.84
Предишно затваряне	1.21

Ocugen Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.06.2026 г., 23:56 ч. UTC

Mondelez International shares declined in after-market trading, continuing a trend of three consecutive lower closes amid rising US Treasury yields and mixed economic signals.

12.06.2026 г., 23:56 ч. UTC

ETF Constituents

Macro News

The U.S. government acquired a 10% stake in USA Rare Earth, boosting investor sentiment for gold-mining firms and contributing to GDX's after-market gains.

12.06.2026 г., 23:51 ч. UTC

Asia equity markets rise on U.S.-Iran peace deal optimism, while U.S. producer prices signal persistent inflation ahead of Fed's interest rate decision.

12.06.2026 г., 23:51 ч. UTC

Global equity markets rise on U.S.-Iran peace deal optimism, while U.S. consumer sentiment improves amid easing inflation concerns.

12.06.2026 г., 23:51 ч. UTC

European equity markets rise on optimism for U.S.-Iran peace deal, despite mixed economic data from the UK and easing inflation in Germany.

12.06.2026 г., 23:51 ч. UTC

US equity markets show mixed performance amid geopolitical developments and rising inflation concerns, with key economic indicators and Fed decisions on the horizon.

12.06.2026 г., 23:51 ч. UTC

U.S. Industrial Production MoM data set for June 15, 2026, forecasts a cautious optimism with a predicted increase of 0.2% following April's strong performance.

12.06.2026 г., 23:51 ч. UTC

United Airlines Holdings Inc. shares declined in after-market trading, despite initial gains, amid rising U.S. Treasury yields and mixed economic signals.

12.06.2026 г., 23:46 ч. UTC

Take-Two Interactive shares are higher in after-market trading, reflecting a modest gain since Friday's close, though still below the 20-day moving average.

12.06.2026 г., 23:46 ч. UTC

JD.Com Inc. shares are higher in after-market trading, despite no specific news. The stock is near the lower end of its one-month range.

12.06.2026 г., 23:46 ч. UTC

ETF Constituents

iShares MSCI South Korea ETF rises in after-hours trading, supported by top holding SKM. Global equity markets remain mixed amid geopolitical developments.

12.06.2026 г., 23:41 ч. UTC

Check Point Software Technologies shares are higher in after-market hours, with trading notably strong despite no specific news driving the movement.

12.06.2026 г., 23:41 ч. UTC

U.S. Retail Sales Expected to Rise 0.5% in May Amid Cautious Consumer Sentiment and Geopolitical Tensions

12.06.2026 г., 23:41 ч. UTC

Cautious Optimism Surrounds Upcoming Canadian Housing Price Index Release Amidst Government Initiatives to Stabilize Market

12.06.2026 г., 23:41 ч. UTC

U.S. Retail Sales Ex Autos Expected to Rise 0.5% in May Amid Economic Uncertainties and Inflation Pressures

12.06.2026 г., 23:41 ч. UTC

Biomarin Pharmaceutical shares traded lower in after-market hours, reflecting broader market dynamics amid rising bond yields and mixed equity performance.

12.06.2026 г., 23:41 ч. UTC

Fox Corp. shares are higher in after-market trading, reflecting a strong upward trajectory since Friday's close amid notable volatility.

12.06.2026 г., 23:41 ч. UTC

Baidu Inc. shares advanced in after-market trading, reaching a session high. The stock remains below its 20-day moving average amid rising bond yields.

12.06.2026 г., 23:41 ч. UTC

Correlated Moves

Bitcoin is trading lower on Friday, influenced by rising bond yields and a broader market decline in cryptocurrencies, including Ethereum.

12.06.2026 г., 23:36 ч. UTC

iShares Core U.S. Aggregate Bond ETF was roughly flat in after-market hours, maintaining stability near the upper end of its one-month trading range.

12.06.2026 г., 23:36 ч. UTC

Ross Stores Inc. shares declined in after-market trading, reflecting routine fluctuations. Broader market conditions were influenced by rising bond yields.

12.06.2026 г., 23:36 ч. UTC

The SPDR S&P Regional Banking ETF traded roughly flat in after-market hours, reflecting routine trading patterns amid mixed direction in broader U.S. stock indices.

12.06.2026 г., 23:31 ч. UTC

ETF Constituents

Macro News

Energy Select Sector SPDR Fund is lower in after-market hours, impacted by declines in Chevron and ExxonMobil, as broader market dynamics influence energy outlook.

12.06.2026 г., 23:31 ч. UTC

Market Awaits U.S. Building Permits Data Amid Mixed Sentiment and Economic Concerns Ahead of June 16 Release.

12.06.2026 г., 23:31 ч. UTC

Trip.com Group Ltd shares are higher in after-market trading, reaching a peak despite three consecutive lower daily finishes and being below its 20-day moving average.

12.06.2026 г., 23:26 ч. UTC

ETF Constituents

Macro News

The Industrial Select Sector SPDR Fund is trading higher in after-market hours, supported by positive industrial sector developments and gains among key holdings.

12.06.2026 г., 23:26 ч. UTC

ETF Constituents

The Materials Select Sector SPDR Fund is trading higher in after-market hours, supported by contributions from Freeport-McMoRan and Albemarle.

12.06.2026 г., 23:22 ч. UTC

Preliminary May 2026 Building Permits Data Set for Release Amid Cautious Optimism Following April's 5.8% Increase

12.06.2026 г., 23:22 ч. UTC

U.S. Export Prices Expected to Surge Amid Optimism from Geopolitical Developments and Recent Inflation Trends Ahead of June 16 Release

12.06.2026 г., 23:22 ч. UTC

Market Awaits May Housing Starts Data Amid Optimism for Real Estate Recovery and Government Initiatives on June 16, 2026.

Сравнение с други в отрасъла

Ценова промяна

Ocugen Inc Прогноза

Ценова цел

By TipRanks

692.62% нагоре

12-месечна прогноза

Среден 9.67 USD 692.62%

Висок 12 USD

Нисък 7 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Ocugen Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Ocugen Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.